SCHEMBL4842682

SCHEMBL4842682

CC1(C)CCCC(SCc2ccccc2C#N)C1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.38
SMN1; SMN2 Q16637 3/20 0.37
NPSR1 Q6W5P4 2/20 0.37
HSD11B1 P28845 1/20 0.36
ALOX15 P16050 1/20 0.34
ATM Q13315 1/20 0.34
HSD17B10 Q99714 1/20 0.34
SLC6A4 P31645 2/20 0.34
TP53 P04637 1/20 0.34
SLC6A2 P23975 1/20 0.34
CNR2 P34972 4/20 0.33
KMT2A Q03164 1/20 0.33
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
OPRM1 P35372 1/20 0.32
OPRL1 P41146 1/20 0.32
HTR2A P28223 1/20 0.32
HTR2C P28335 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4632635 0.77 DDB1 (0.44)
SCHEMBL2581431 0.76 MAOB (0.40) ALDH1A1SMN1; SMN2KMT2ARAB9A
SCHEMBL2587085 0.69 KMT2A (0.39) KMT2A
SCHEMBL515046 0.65 ALDH1A1 (0.49) ALDH1A1SMN1; SMN2NPSR1HSD11B1ALOX15
SCHEMBL611198 0.62 QRFPR (0.37) ALDH1A1SMN1; SMN2ALOX15KMT2ARAB9A
SCHEMBL515045 0.62 ALDH1A1 (0.49) ALDH1A1SMN1; SMN2NPSR1HSD11B1ALOX15
SCHEMBL18896291 0.62 ALDH1A1 (0.49) ALDH1A1SMN1; SMN2NPSR1HSD11B1ALOX15
SCHEMBL2579025 0.61 MAOA (0.38) ALDH1A1HSD11B1
SCHEMBL14394526 0.60 KMT2A (0.45) ALDH1A1SMN1; SMN2ALOX15HSD17B10KMT2A
Acetonitrile SCHEMBL27498741 0.60 TRPA1 (0.59)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1924561-A2 6-ARYLALKYLAMINO- 2,3,4,5-TETRAHYDRO-1H-BENZO[D]AZEPINES AS 5-HT2C RECEPTOR AGONISTS Eli Lilly & Company (US) 2008-05-28 EP disclosed
WO-2007028083-A2 6-ARYLALKYLAMINO- 2,3,4,5-TETRAHYDRO-1H-BENZO[D]AZEPINES AS 5-HT2C RECEPTOR AGONISTS ELI LILLY AND COMPANY (US) 2007-03-08 WO disclosed